Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis

被引：5
|
作者：
Felson, David [1 ]
Smolen, Josef S. [2 ]
机构：
[1] Boston Univ, Sch Med, Boston, MA 02118 USA
[2] Med Univ Vienna, Vienna, Austria
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年 / 384卷 / 01期
关键词：
D O I：
10.1056/NEJMc2033206
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 83
页数：1
相关论文
共 50 条
  • [21] Abatacept: A Review in Rheumatoid Arthritis
    Hannah A. Blair
    Emma D. Deeks
    Drugs, 2017, 77 : 1221 - 1233
  • [22] Abatacept in the treatment of rheumatoid arthritis
    Posadas, Augusto
    Lisse, Jeffrey
    Sarkar, Sujata
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (01) : 9 - 17
  • [23] Abatacept in the treatment of rheumatoid arthritis
    Buch, Maya H.
    Vital, Edward M.
    Emery, Paul
    ARTHRITIS RESEARCH & THERAPY, 2008, 10 (Suppl 1)
  • [24] Abatacept for subclinical rheumatoid arthritis
    Brooks, Helen
    Clark, Anna
    Van Epps, Heather
    LANCET RHEUMATOLOGY, 2022, 4 (01): : E18 - E18
  • [25] MALIGNANCY IN THE UPADACITINIB CLINICAL TRIAL PROGRAMS FOR RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND ANKYLOSING SPONDYLITIS
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Nash, Peter
    Curtis, Jeffrey
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 44 - 44
  • [26] Malignancy in the Upadacitinib Clinical Trial Programs for Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
    Rubbert-Roth, Andrea
    Kakehasi, Adriana
    Takeuchi, Tsutomu
    Schmalzing, Marc
    Palac, Hannah
    Liu, Jianzhong
    Anyanwu, Samuel
    Lippe, Ralph
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 562 - 564
  • [27] Impact of Upadacitinib Versus Abatacept on Individual Disease Outcomes in Pts With Rheumatoid Arthritis and Inadequate Responses to Biologic DMARDS
    van Vollenhofen, R.
    Rubbert-Roth, A.
    Hall, S.
    Xavier, R.
    Shmagel, A.
    Song, Y.
    Anyanwu, S.
    Strand, V
    SWISS MEDICAL WEEKLY, 2023, 153 : 27S - 27S
  • [28] Impact of Upadacitinib versus Abatacept on Individual Disease Outcomes in Patients with Rheumatoid Arthritis and Inadequate Responses to Biologic DMARDs
    van Vollenhoven, Ronald
    Rubbert-Roth, Andrea
    Hall, Stephen
    Xavier, Ricardo
    Shmagel, Anna K.
    Song, Yanna
    Anyanwu, Samuel
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2812 - 2814
  • [29] IMPACT OF UPADACITINIB VERSUS ABATACEPT ON INDIVIDUAL DISEASE OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSES TO BIOLOGIC DMARDS
    Van Vollenhoven, R.
    Rubbert-Roth, A.
    Hall, S.
    Xavier, R.
    Shmagel, A.
    Song, Y.
    Anyanwu, S.
    Strand, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 626 - 626
  • [30] ABATACEPT IN INDIVIDUALS AT RISK OF DEVELOPING RHEUMATOID ARTHRITIS: RESULTS FROM THE ARTHRITIS PREVENTION IN THE PRECLINICAL PHASE OF RA WITH ABATACEPT (APIPPRA) TRIAL
    Cope, A.
    Jasenecova, M.
    Vasconcelos, J.
    Filer, A.
    Raza, K.
    Qureshi, S.
    D'agostino, M. A.
    Mcinnes, I.
    Isaacs, J.
    Pratt, A.
    Fisher, B.
    Buckley, C. D.
    Emery, P.
    Ho, P.
    Buch, M. H.
    Ciurtin, C.
    Huizinga, T.
    Van Schaardenburg, D.
    Murphy, C.
    Prevost, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 86 - 86
12345